Almirall SA - Company Profile
Powered by 
All the data and insights you need on Almirall SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Almirall SA Strategy Report
- Understand Almirall SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Almirall SA’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Almirall SA's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Carlos Gallardo Pique
Chairman; Chief Executive Officer; Director - Proprietary Executive BoardMr. Carlos Gallardo has been the Chief Executive Officer of the company since 2023. Earlier he worked as Chairman and Proprietary Director of the company since 2022. Prior to this role, he served as President in the company. Previously, he served as Second Vice President of Almirall’s Board of Directors. Earlier, he served as General Manager of the UK and Ireland in 2013.
Mike McClellan
Chief Financial Officer; Executive Vice President - Finance Senior ManagementMr. Mike McClellan has been the Executive Vice President, Finance and Chief Financial Officer since 2019. Prior to this, he was the Chief Financial Officer of Teva Pharmaceuticals and had also served in various leadership positions at Sanofi.
Mercedes Diz
Chief Marketing Officer Senior ManagementMs. Mercedes Diz has been the Chief Marketing Officer of the company since 2023. Prior to this, she served as Vice President of Corporate Strategy. She handled the commercial activities in Austria, Belgium, Netherlands, Nordics, Poland, Switzerland, and the UK locations.
Volker Koscielny
Chief Medical Officer Senior ManagementMr. Volker Koscielny is the Chief Medical Officer. Prior to this, he served in various positions at Celgene, GlaxoSmithKline, Pfizer and Servier.
Karl Ziegelbauer
Executive Vice President - R&D; Chief Scientific Officer Senior ManagementMr. Karl Ziegelbauer has been the Executive Vice President of R&D and the Chief Scientific Officer of the company since 2021. Most recently he served as Senior Vice President and Head of Open Innovation & Digital Technologies at Bayer Pharmaceuticals.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer